Concepedia

Karin Rydström

KR

6

Publications

93

Citations

6

H-Index

2010

Active since

Affiliations

Lund University(Current)

Helsinki University Hospital

Skåne University Hospital

University of Helsinki

Karin Rydström is an author at Lund University specializing in medicine, immunology, and tumor biology.

Top concepts

Publications per year

2010–2013

6

Publications

6

The histone deacetylase inhibitor valproic acid sensitizes diffuse large B-cell lymphoma cell lines to CHOP-induced cell death.

Malin Ageberg, Karin Rydström, Thomas Relander et al. · PubMed · 2013 · 20 citations · Full text

, , +17

Prognostic impact of protein kinase C β II expression in R-CHOP-treated diffuse large B-cell lymphoma patients

Sari Riihijärvi, Satu Koivula, Heidi Nyman et al. · Modern Pathology · 2010 · 19 citations · Full text

, , +6

Inhibition of geranylgeranylation mediates sensitivity to CHOP-induced cell death of DLBCL cell lines

Malin Ageberg, Karin Rydström, Ola Lindén et al. · Experimental Cell Research · 2011 · 16 citations

, , +10

CD40 is a potential marker of favorable prognosis in patients with diffuse large B-cell lymphoma treated with immunochemotherapy

Karin Rydström, Johan Linderoth, Heidi Nyman et al. · Leukemia & lymphoma/Leukemia and lymphoma · 2010 · 14 citations · Full text

, , +18

High serum vascular endothelial growth factor level is an adverse prognostic factor for high‐risk diffuse large <scp>B</scp>‐cell lymphoma patients treated with dose‐dense chemoimmunotherapy

Sari Riihijärvi, Heidi Nurmi, Harald Holte et al. · European Journal Of Haematology · 2012 · 13 citations

Rows per page

1–5 of 6